$6.49
0.040.62%
Últ. Act.: Oct 22, 4:00 PM
$6.49
0.040.62%
Bausch Health Companies (BHC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Bausch Health Companies (BHC) publicó su última previsión de julio 29, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $10.79B - $11.04B para el período.
En comparación con la previsión anterior, Bausch Health Companies elevado redujo su previsión de ingresos desde un rango anterior de $10.67B - $10.92B.
Bausch Health Companies ha emitido 17 actualizaciones de orientación entre el noviembre 3, 2022 y el julio 29, 2026. During this period, the company raised its outlook 8 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.01 | $0.72 | $1.24 | $1.06 |
| Actual | $1.26 | $0.78 | $1.10 | $1.16 |
| Surprise | +24.8% | +8.33% | -11.3% | +9.43% |
| Revenue | ||||
| Estimate | $2.66B | $2.41B | $2.70B | $2.62B |
| Actual | $2.85B | $2.52B | $2.80B | $2.68B |
| Surprise | +7.37% | +4.82% | +3.38% | +2.51% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $1.21 | $1.26 | $0.86 |
| Revenue | |||
| Consensus | $2.75B | $2.80B | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $1.26 | $1.01 | 24.8 % |
| Q1 | Apr 29, 2026 | $0.78 | $0.72 | 8.33 % |
| Q4 | Feb 18, 2026 | $1.10 | $1.24 | -11.3 % |
| Q3 | Oct 29, 2025 | $1.16 | $1.06 | 9.43 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $2.85B | $2.66B | 7.37 % |
| Q1 | Apr 29, 2026 | $2.52B | $2.41B | 4.82 % |
| Q4 | Feb 18, 2026 | $2.80B | $2.70B | 3.38 % |
| Q3 | Oct 29, 2025 | $2.68B | $2.62B | 2.51 % |